Oracle
ORCL
Amazon
AMZN
Apple
AAPL
Alphabet-A
GOOGL
Meta Platforms
META
US Stock MarketDetailed Quotes
DAWN Day One Biopharmaceuticals
- 12.570
- +0.040+0.32%
Trading Dec 19 13:25 ET
1.27BMarket Cap-12.96P/E (TTM)
12.670High12.340Low375.40KVolume12.560Open12.530Pre Close4.70MTurnover0.54%Turnover RatioLossP/E (Static)100.85MShares18.07052wk High2.28P/B872.56MFloat Cap11.94052wk Low--Dividend TTM69.42MShs Float28.699Historical High--Div YieldTTM2.63%Amplitude5.440Historical Low12.523Avg Price1Lot Size
About Day One Biopharmaceuticals Company
Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in Brisbane, CA.
Company Profile
SymbolDAWN
Company NameDay One Biopharmaceuticals
Listing DateMay 27, 2021
Issue Price16.00
Founded2018
CEODr. Jeremy Bender
MarketNASDAQ
Employees155
Fiscal Year Ends12-31
Address2000 Sierra Point Parkway,Suite 501
CityBrisbane
ProvinceCalifornia
CountryUnited States of America
Zip Code94005
Phone1-650-484-0899
Websitehttp://www.dayonebio.com
Company Executives
- Name
- Position
- Salary
- Dr. Jeremy Bender
- Chief Executive Officer, President and Director
- 6.91M
- Charles N. York, II
- Principal Accounting Officer, Chief Operating Officer, Chief Financial Officer and Secretary
- 3.55M
- Adam Dubow
- General Counsel and Chief Compliance Officer
- 2.77M
- Garry A. Nicholson
- Chairman of the Board
- 383.38K
- Habib Joseph Dable
- Director
- --
- Dr. William Grossman
- Director
- --
- Saira Ramasastry, M.Phil,M.S.
- Independent Director
- 351.75K
- Michael Gladstone
- Independent Director
- 342.88K
- Scott Garland
- Independent Director
- 342.88K
- Natalie C. Holles
- Lead Independent Director
- 352.50K
- Dr. John A. Josey, PhD
- Independent Director
- 350.75K
- Dr. Samuel Blackman, M.D.
- Head of Research and Development
- 2.49M
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.